Steamboat Capital Partners LLC Buys Shares of 125,000 Tenet Healthcare Co. (NYSE:THC)

Steamboat Capital Partners LLC bought a new stake in Tenet Healthcare Co. (NYSE:THCFree Report) during the first quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 125,000 shares of the company’s stock, valued at approximately $7,428,000. Tenet Healthcare comprises 2.5% of Steamboat Capital Partners LLC’s holdings, making the stock its 19th biggest holding. Steamboat Capital Partners LLC owned approximately 0.12% of Tenet Healthcare as of its most recent SEC filing.

A number of other hedge funds also recently added to or reduced their stakes in THC. BlackRock Inc. raised its stake in shares of Tenet Healthcare by 14.7% during the first quarter. BlackRock Inc. now owns 11,639,373 shares of the company’s stock valued at $691,612,000 after purchasing an additional 1,491,799 shares in the last quarter. Norges Bank bought a new stake in shares of Tenet Healthcare during the fourth quarter valued at about $65,580,000. Glenview Capital Management LLC raised its stake in shares of Tenet Healthcare by 9.8% during the fourth quarter. Glenview Capital Management LLC now owns 8,896,111 shares of the company’s stock valued at $434,041,000 after purchasing an additional 796,463 shares in the last quarter. Greenlight Capital Inc. raised its stake in shares of Tenet Healthcare by 116.6% during the first quarter. Greenlight Capital Inc. now owns 1,426,970 shares of the company’s stock valued at $84,791,000 after purchasing an additional 768,070 shares in the last quarter. Finally, Avidity Partners Management LP bought a new stake in shares of Tenet Healthcare during the fourth quarter valued at about $34,997,000. 93.56% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently weighed in on the stock. Credit Suisse Group lifted their price objective on shares of Tenet Healthcare from $92.00 to $98.00 and gave the company an “outperform” rating in a research note on Wednesday, August 2nd. UBS Group boosted their price target on shares of Tenet Healthcare from $95.00 to $104.00 and gave the stock a “buy” rating in a research report on Tuesday, August 1st. Royal Bank of Canada boosted their price target on shares of Tenet Healthcare from $84.00 to $87.00 and gave the stock an “outperform” rating in a research report on Tuesday, August 1st. Stephens boosted their price target on shares of Tenet Healthcare from $87.00 to $89.00 and gave the stock an “equal weight” rating in a research report on Tuesday, August 1st. Finally, Citigroup boosted their price target on shares of Tenet Healthcare from $83.00 to $90.00 and gave the stock a “buy” rating in a research report on Tuesday, August 1st. One research analyst has rated the stock with a hold rating, fourteen have assigned a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, Tenet Healthcare has a consensus rating of “Buy” and an average price target of $82.94.

Check Out Our Latest Report on Tenet Healthcare

Tenet Healthcare Stock Down 1.9 %

NYSE:THC traded down $1.39 on Tuesday, hitting $72.00. 681,143 shares of the company’s stock traded hands, compared to its average volume of 1,419,174. The company has a current ratio of 1.44, a quick ratio of 1.35 and a debt-to-equity ratio of 5.47. Tenet Healthcare Co. has a 1 year low of $36.69 and a 1 year high of $85.40. The firm has a 50-day moving average price of $76.53 and a 200-day moving average price of $70.46. The company has a market cap of $7.31 billion, a PE ratio of 16.13, a price-to-earnings-growth ratio of 1.96 and a beta of 2.13.

Tenet Healthcare (NYSE:THCGet Free Report) last released its earnings results on Monday, July 31st. The company reported $1.44 earnings per share for the quarter, beating the consensus estimate of $1.26 by $0.18. Tenet Healthcare had a return on equity of 26.60% and a net margin of 2.51%. The company had revenue of $5.08 billion for the quarter, compared to analysts’ expectations of $4.91 billion. During the same quarter in the previous year, the business posted $1.50 EPS. The business’s revenue for the quarter was up 9.6% on a year-over-year basis. Equities analysts anticipate that Tenet Healthcare Co. will post 5.73 EPS for the current fiscal year.

Tenet Healthcare Profile

(Free Report)

Tenet Healthcare Corporation operates as a diversified healthcare services company. The company operates through three segments: Hospital Operations, Ambulatory Care, and Conifer. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.

See Also

Want to see what other hedge funds are holding THC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Tenet Healthcare Co. (NYSE:THCFree Report).

Institutional Ownership by Quarter for Tenet Healthcare (NYSE:THC)

Receive News & Ratings for Tenet Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenet Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.